Income taxes - Reconciliation of Federal Statutory Income Tax Provision to Company's Actual Provision (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Income Tax Disclosure [Line Items] | ||
| Federal statutory income tax rate (percent) | 21.00% | |
| Pre-tax book income | $ 3,760,508 | |
| Deferred tax past year true-up's | 84,000 | |
| Change in valuation allowance | $ 843,000 | |
| Income tax provision | 16,352 | 19,491 |
| Income Tax Provision | ||
| Income Tax Disclosure [Line Items] | ||
| Pre-tax book income | (2,381,360) | 3,760,508 |
| Expected tax at 21% | (500,086) | 789,707 |
| Mark to market | (3,937) | 6,605 |
| Intangible amortization | (89,480) | (67,008) |
| Paycheck protection program loan forgiveness | 0 | (792,333) |
| Other | 2,404 | 3,873 |
| Current | 16,352 | 19,491 |
| Deferred | (162,688) | (15,672) |
| Federal research and development credits | (7,647) | 9,551 |
| Deferred tax past year true-up's | (46,786) | |
| Change in valuation allowance | 668,326 | (15,228) |
| Capitalized research and development expenses | 174,674 | 0 |
| Other | (34,780) | (3,495) |
| Income tax provision | $ 16,352 | $ 19,491 |
| X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, Mark to Market, Amount No definition available.
|
| X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount, Current No definition available.
|
| X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount, Deferred No definition available.
|
| X | ||||||||||
- Definition [Line Items] for Income Tax Disclosure [Table] No definition available.
|
| X | ||||||||||
- Definition Income Tax Reconciliation, Unbenefited Operating Losses No definition available.
|
| X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible amortization. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|